ZEISS Launches World's First Bitoric Hydrophobic Monofocal IOL
Event summary
- ZEISS AT LUCIA toric 721P, the world's first bitoric hydrophobic monofocal IOL, is now commercially available in select European countries.
- The product features a non-constant asphericity profile design and is CE marked.
- Launch event at ESCRS in London from September 11–14, 2026, with surgeon testimonials.
- Product aims to treat cataracts while simultaneously correcting astigmatism.
- ZEISS highlights the lens's reliability and stability in real-world conditions.
The big picture
ZEISS's launch of the AT LUCIA toric 721P underscores its commitment to advancing ophthalmology with innovative optics. The product's unique design addresses both cataracts and astigmatism, potentially setting a new standard in intraocular lenses. With a growing aging population and increasing demand for cataract surgery, ZEISS is well-positioned to capitalize on this market trend. The company's strategic focus on optics expertise and surgeon satisfaction could drive long-term growth in its ophthalmology segment.
What we're watching
- Market Adoption
- How quickly the ZEISS AT LUCIA toric 721P will be adopted by surgeons and patients in Europe and beyond.
- Competitive Response
- Whether competitors will introduce similar bitoric hydrophobic monofocal IOLs to challenge ZEISS's market position.
- Regulatory Approvals
- The pace at which the product gains regulatory approvals in additional markets outside Europe.